In vitro efficiency of 9-(N-cinnamoylbutyl)aminoacridines against blood- and liver-stage malaria parasites.
Bianca Pérez, Cátia Teixeira, Ana S Gomes, Inês S Albuquerque, Jiri Gut, Philip J Rosenthal, Miguel Prudêncio, Paula Gomes
Index: Bioorg. Med. Chem. Lett. 23(3) , 610-3, (2013)
Full Text: HTML
Abstract
Novel 9-aminoacridine derivatives were synthesized by linking the heteroaromatic core to different cinnamic acids through an aminobutyl chain. The test compounds demonstrated mid-nanomolar in vitro activity against erythrocytic stages of the chloroquine-resistant W2 strain of the human malaria parasite Plasmodium falciparum. Two of the most active derivatives also showed in vitro activity against liver-stage Plasmodium berghei, with activity greater than that of the reference liver-stage antimalarial primaquine. The compounds were not toxic to human hepatoma cells at concentrations up to 5 μM. Hence, 9-(N-cinnamoylbutyl)aminoacridines are a new class of leads for prevention and treatment of malaria.Copyright © 2012 Elsevier Ltd. All rights reserved.
Related Compounds
Related Articles:
2014-07-01
[Int. J. Pharm. 468(1-2) , 243-9, (2014)]
2006-01-01
[Bioorg. Khim. 32(4) , 446-7, (2006)]
2012-07-01
[Eur. J. Med. Chem. 53 , 1-12, (2012)]
2013-02-01
[Bioorg. Med. Chem. Lett. 23(3) , 740-3, (2013)]
1983-04-01
[J. Pharm. Sci. 72(4) , 369-72, (1983)]